Golden Leaf Holdings Announces Partial Close of Non-Brokered Private Placement
NOT FOR RELEASE IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES PORTLAND, Ore., March 04, 2021 (GLOBE...
Month: March 2021
Ocuphire to Participate in March Investor Conferences
HC Wainwright Life Sciences Conference beginning at 7:00 am ET on March 9thOppenheimer Healthcare Conference at 9:20 am ET on...
PsyBio Therapeutics Announces Retention of Market Maker
TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (TSXV:PSYB) (“PsyBio” or the “Company”), a leader in the field of psychedelic research and...
Landmark Study by Boston Cell Standards Validates First Reference Standards for Immunohistochemistry Testing
BOSTON, March 04, 2021 (GLOBE NEWSWIRE) -- Boston Cell Standards announced the publication this month of a Canadian national study...
Mustang Bio to Participate in Three March 2021 Virtual Investor Conferences
WORCESTER, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on...
X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
2021 expected to be a year of key value-driving catalysts as company advances multiple clinical programs with lead candidate mavorixafor Company...
Fortress Biotech to Participate in Four March 2021 Virtual Investor Conferences
NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative revenue-generating company focused on...
Spectral Medical Engages Crescendo Communications to Provide Investor Relations Services in the United States
TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic...
Oncternal Therapeutics to Report Fourth Quarter 2020 Financial Results and Provide Business Update
SAN DIEGO, March 04, 2021 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the...
Amunix Raises $117 Million Series B Financing to Fund its Oncology Pipeline
Proceeds will fund advancement of the company’s pipeline of protease-activated T cell engagers and cytokines for the treatment of solid...
eGenesis Appoints Veteran Financial Executive, Sapna Srivastava, Ph.D., as Chief Financial Officer
CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing and genome-engineering company developing human-compatible organs, tissues, and cells,...
F-star Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical...
Philips Incisive CT gets even smarter with debut of AI-enabled Precise Suite
Philips Incisive CT in use with patient Philips Incisive CT in use by tech operator Precise Suite Incisive carotid Precise...
Decibel Therapeutics to Present at the Barclays Global Healthcare Conference
BOSTON, March 04, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing...
Galectin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
NORCROSS, Ga., March 04, 2021 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin...
Healthcare Venture Capital Firm Longitude Capital Promotes Brian Liu to Principal
MENLO PARK, Calif. and GREENWICH, Conn. and BOSTON, March 04, 2021 (GLOBE NEWSWIRE) -- Longitude Capital, a leading healthcare venture...
Ortho Clinical Diagnostics to Report Fourth Quarter and Full Year 2020 Results on March 18, 2021
RARITAN, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest...
Nemaura Medical Appoints Industry Veteran Alistair Longmuir as Advisor on Global Product Manufacture Strategy
Loughborough, England, March 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology...
Selecta Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2020 Financial Results and Recent Operational Highlights
WATERTOWN, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...
Replimune to Present at Three Upcoming Investor Conferences
WOBURN, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies...